NUVOX PHARMA
NuvOx Pharma is developing a is developing a platform of drugs that, upon intravenous injection, flow through the bloodstream arriving first at the lungs to pick up oxygen and finally to hypoxic tissue where they passively deliver the oxygen. Indications for NuvOx's drug include Stroke (Phase II ready), Oncology (Phase II ready), and Sickle Cell Crisis (Phase Ib ready).
NUVOX PHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2008-01-01
Address:
Tucson, Arizona, United States
Country:
United States
Website Url:
http://www.nuvoxpharma.com
Total Employee:
11+
Status:
Active
Contact:
520.624.6688
Total Funding:
17.09 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Euro Microsoft Exchange Online Google Google Cloud
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - NuvOx Pharma
National Institutes of Health
National Institutes of Health investment in Grant - NuvOx Pharma
Official Site Inspections
http://www.nuvoxpharma.com Semrush global rank: 4.43 M Semrush visits lastest month: 2.5 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "NuvOx Pharma"
Innovative Oxygen Therapeutics | NuvOx Pharma | Arizona
NuvOx Pharma is a clinical stage pharmaceutical company developing a drug that improves the flow of oxygen from lungs to blood and from blood to tissue. Over 30 animal studies have …See details»
NuvOx Pharma Leadership
Dr. Jennifer Johnson is a co-founder of NuvOx. She brings more than 20 years of deep R&D and regulatory experiences. Dr. Johnson specializes in pharmacokinetics, formulation, biostatistics, and project management.See details»
NuvOx Pharma - Crunchbase Company Profile & Funding
NuvOx Pharma is develops a nanotechnology for oxygen delivery, DDFPe that is phase II ready in stroke. View contacts for NuvOx Pharma to access new leads and connect with decision-makers.See details»
NuvOx Pharma - LinkedIn
NuvOx Pharma is a biotechnology company based in Tucson, Arizona that is developing a first-in-class oxygen therapeutic to treat life-threatening diseases where hypoxia plays a role. Over 30...See details»
NuvOx Pharma LLC Announces Authorization of ARDS Trial from …
Jul 11, 2024 · Tucson, AZ, June 30th, 2024 – NuvOx Pharma LLC (“NuvOx”) announced that it has received authorization from Health Canada for its EXTEND: novEl oXygen ThErapeutic …See details»
NuvOx Therapeutics Inc – Mobilizing Oxygen, Transforming Lives
Our first-in-class oxygen therapeutic will treat life-threatening diseases where hypoxia plays a role (hypoxia weakens effectiveness for cancer treatments and causes brain death in stroke). Our …See details»
NuvOx Pharma Company Profile 2024: Valuation, …
Developer of a pharmaceutical company designed to treat life-threatening diseases.See details»
NuVox Pharma | Seed
NuvOx Pharma is a clinical stage pharmaceutical company developinga first-in-class oxygen therapeutic to treat life-threatening diseases where hypoxia plays a role. Over 30 animal …See details»
NuvOx Therapeutics Inc First-in-Class Oxygen Therapeutic …
Our first-in-class oxygen therapeutic will treat life-threatening diseases where hypoxia plays a role (hypoxia weakens effectiveness for cancer treatments and causes brain death in stroke). Our …See details»
Microbubbles Improve Dangerously Low Oxygen Levels in Cancer …
In 2008, Unger co-founded NuvOx Pharma with Jenny Johnson and Terry Matsunaga to develop a new way to deliver oxygen to patients sufering from the low oxygen levels associated with …See details»
NUVOX PHARMA, LLC - VentureRadar
Website: http://www.nuvoxpharma.com/ Develops an innovative oxygen therapeutics platform targeting life-threatening diseases involving hypoxia, such as oncology and stroke treatments. …See details»
NuvOx Pharma Announces Issuance of a New Patent | AZBio
Tucson, AZ, January 14, 2024 – (PR.com)– NuvOx Pharma has been issued US Patent No. 11,857,627, entitled “Fractionated Radiotherapy and Chemotherapy with an Oxygen …See details»
NuvOx Pharma Receives FDA Allowance to Proceed with Phase II …
Tucson, AZ, July 29, 2021 -- (PR.com)-- NuvOx Pharma, a Tucson-based biopharmaceutical company, has received notice from the FDA that they may proceed with a Phase II clinical trial …See details»
NuvOx Announces Contract to Support NOVEL Trial
Nov 2, 2023 · Tucson, AZ, USA, October 31, 2023 - NuvOx Pharma (NuvOx), a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases …See details»
NuvOx Pharma - Overview, News & Similar companies - ZoomInfo
NuvOx Pharma contact info: Phone number: (520) 624-6688 Website: www.nuvoxpharma.com What does NuvOx Pharma do? NuvOx Pharma is a privately held Phase IIb ready company …See details»
NuvOx Pharma LLC Announces Authorization of ARDS Trial from
Jul 8, 2024 · NuvOx Pharma LLC (“NuvOx”) announced that it has received authorization from Health Canada for its EXTEND: novEl oXygen ThErapeutic NanO2 for mild respiratory distress …See details»
FDA Allows NuvOx Pharma’s IND to Initiate Phase Ib Clinical
Evan Unger, MD, President and CEO of NuvOx, announced that the FDA has allowed an investigational new drug application (IND) for NVX-208 (dodecafluoropentane emulsion) to be …See details»
Microbubbles Improve Dangerously Low Oxygen Levels in Cancer …
Sep 15, 2022 · In 2008, Unger co-founded NuvOx Pharma with Jenny Johnson and Terry Matsunaga to develop a new way to deliver oxygen to patients suffering from the low oxygen …See details»
NuvOx Pharma Generates Positive Preclinical Data Showing
Tucson, AZ, September 09, 2021 – (PR.com)– NuvOx Pharma, a biotechnology company based in Tucson, Arizona, has generated positive preclinical data showing that its lead drug, …See details»
RiboMed and NuvOx Pharma to Collaborate on Brain Cancer Drug …
Dec 5, 2013 · RiboMed Biotechnologies, Inc. and NuvOx Pharma today jointly announced that they have entered into a collaborative agreement that will utilize RiboMed’s epigenetic …See details»